| Financial Year |
March 31 2023 |
| Monetary Funds |
449,427,872.23 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
11,009,036.63 |
| Accounts Receivable |
505,960,588.66 |
| Advances to Suppliers |
72,000,540.29 |
| Other Receivables |
19,663,803.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
655,732,970.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,325,184.43 |
| Total Current Assets |
1,780,380,733.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
420,714,351.26 |
| Investment Properties |
12,797,148.01 |
| Fixed Assetes |
714,104,679.45 |
| Under-construction Projects |
25,210,045.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
90,787,062.01 |
| R&D expenses |
4,729,006.53 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,231,507.78 |
| Deferred Income Tax Assets |
56,517,392.14 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,331,091,192.66 |
| Total Assets |
3,111,471,925.81 |
| Short-Term Loans |
374,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
121,321,516.94 |
| Accounts Payable |
434,278,233.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,719,689.17 |
| Taxes Payable |
6,137,700.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
77,285,047.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
15,737,158.57 |
| Sub-Total of Current Liabilities |
1,124,052,275.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,000,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
82,382,382.98 |
| Total Liabilities |
1,206,434,658.16 |
| Paid-In Capital(Or Share Stock) |
638,206,348.00 |
| Capital Surplus |
1,211,283,571.56 |
| Surplus Reserve |
47,166,045.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-53,724,801.81 |
| Minority Stockholder's Interest |
55,397,202.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,849,640,065.09 |
| Owner's Equity（Stockholder's Equity） |
1,905,037,267.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,111,471,925.81 |
